The sand fly-borne Toscana virus (TOSV) is the major cause of human meningoencephalitis in the Mediterranean basin during the summer season. In this work, we have developed a T7 RNA polymerase-driven reverse genetics system to recover infectious particles of a lineage B strain of TOSV. The viral protein pattern and growth properties of the rescued virus (rTOSV) were found to be similar to those of the corresponding wild-type (wt) virus. Using this system, we genetically engineered a TOSV mutant lacking expression of the non-structural protein NSs (rTOSV Viruses 2019, 11, x FOR PEER REVIEW and Proteomics Core Facility of the German Cancer Research Center, Heidelberg (Table 1). B viruses were produced and purified, as described in Section 2.5. Soluble ectodomains of GN a were stably expressed in drosophila S2 cells and purified according to a standard procedure Using these protocols, the protein purity reached over 90%. Antisera were prepared in guinea by injecting 100 µg of Triton X-100-inactivated purified viruses or soluble ectodomains of GN a in Freund's complete adjuvant. The priming was followed by three booster injections of 100 µg week intervals, the first one in Freund's incomplete adjuvant, and the others in phosphate-bu saline (PBS). Animals were bled before the first immunization (control pre-immune serum) days after the last injection. The purified rabbit polyclonal antibodies against the TOSV nucleop N (T4) and non-structural protein NSs (T5) were developed by GenScript (Piscataway Netherlands). Rabbits were immunized with either a peptide corresponding to the C termin amino acid residues of NSs or the full-length N protein with a C-terminal His-tag. The m immune ascitic fluid against all TOSV structural proteins was a generous gift from R.B. (University of Texas, Galveston, Texas, USA). s were constructed by GenScript. Briefly, the cDNAs encoding the full-length S, M, and f TOSV, flanked by an upstream T7 polymerase promoter sequence and a downstream ta virus (HdV) ribozyme sequence ( Figure S1), were synthesized. The gene synthesis e subjected to blunt-end ligation into EcoRV-linearized pUC57 plasmid, or alternatively, into the pCC1 plasmid, using the CloneEZ PCR Cloning Kit (Genscript), resulting in C1-M, and pUC57-L. In addition, a pUC57-SɸNSs was created in which the S segment mRNA, with the 18 first AUG codons replaced by UAG stop codons ( Figure S2).
Viruses from Plasmid DNAscells expressing T7 polymerase were seeded in 6-well plates (2.5 × 10 5 cells per well). g day, rTOSV was rescued from cells by transfection with 1 µg each of the plasmids C1-M, and pUC57-L. Alternatively, the recovery of rTOSVɸNSs was achieved following thod but using the plasmid pUC57-SɸNSs instead of the pUC57-S. Transfection was ith Lipofectamine 2000 (Thermo Fisher Scientific), using a ratio of 1 µL Lipofectamine of plasmids in 400 µL of complete GMEM without antibiotics. Supernatants were fresh culture medium containing antibiotics and 2% serum 4 h post-transfection. Five nsfection, supernatants were harvested, c...